Brief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
13/05/2026 23:39
May 13 (Reuters) - Armata Pharmaceuticals Inc ARMP.A: ARMATA PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2026 RESULTS AND PROVIDES CORPORATE UPDATE ARMATA PHARMACEUTICALS INC - ENTERS SECURED CREDIT AGREEMENT WITH INNOVIVA FOR $25 MILLION MATURING IN 2029 ARMATA PHARMACEUTICALS INC - Q1 NET LOSS $115.3 MILLION OR $3.16 LOSS PER SHARE VERSUS $6.5 MILLION OR $0.18 LOSS YEAR AGO Source text: ID:nPn7y94LBa Further company coverage: ARMP.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles